红色球体转录因子的分离与骨髓分裂综合征的治疗反应有关
Srinivas Aluri1, Te Ling2, Ellen Fraint3
1Department of Medicine, Albert Einstein College of Medicine, New York, New York, USA.
The Journal of clinical investigation
|May 27, 2025
概括
增长分化因子11 (GDF11) 通过产生受损的GATA1异型,驱动肌肉发育综合征 (MDS) 中的贫血. 路斯帕特塞普特治疗可以通过降低GATA1s来逆转这种情况,从而改善红细胞的产生.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 贫血是骨髓质疏松症候群 (MDS) 的关键症状,但其潜在的分子原因尚未完全理解.
- 卢斯帕特塞普特是一种已批准用于MDS相关贫血的治疗方法,但其精确的作用机制需要阐明.
研究的目的:
- 研究驱动MDS中无效的红色素形成的分子机制.
- 为了澄清卢斯帕特塞普特在治疗MDS相关性贫血中的作用机制.
主要方法:
- 分析患者样本和体外红色素形成试验.
- 利用斑马鱼和小鼠模型研究贫血和治疗效果.
- 使用CRISPR基因编辑和RNA测序 (RNA-Seq) 进行分子分析.
主要成果:
- 在MDS患者中,生长分化因子11 (GDF11) 和SMAD2的上调.
- GDF11抑制了红质形成和诱导贫血,效果被luspatercept阻止.
- 刺激GDF11导致通过SMAD2结合增加了功能受损的GATA1异型 (GATA1s) 的产生.
- 卢斯帕特塞普特反应者显示出更高的基线GATA1s水平,治疗与减少GATA1s和增加红细胞相关.
结论:
- 通过GDF11介导的SMAD2激活会增加功能受损的GATA1异型,导致MDS贫血.
- 这一途径与MDS患者对卢斯帕特塞普特的治疗反应有关.
相关概念视频
Alternative RNA Splicing
21.8K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.8K
RNA Splicing
57.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.2K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Erythropoiesis
4.9K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.9K
General Transcription Factors
5.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.6K


